Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2025 Earnings Call Transcript May 1, 2025
Travere Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.55.
Operator: Good afternoon, and welcome to the Travere Therapeutics First Quarter and Full Year 2025 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the conference call over to Victoria Prescott, Manager of Investor Relations. Please go ahead,...
